Max Healthcare Financials
MAXHEALTH | 973.80 4.30 0.44% |
Operating Margin | PE Ratio 96.0662 | Profit Margin | Payout Ratio 0.1376 | EPS Estimate Current Year 14.7573 |
Max | Select Account or Indicator |
Max Healthcare Stock Summary
Max Healthcare competes with Uniinfo Telecom, LT Technology, Syrma SGS, Shyam Telecom, and Newgen Software. Max Healthcare is entity of India. It is traded as Stock on NSE exchange.Specialization | Health Care, Health Care Equipment & Services |
Instrument | India Stock View All |
Exchange | National Stock Exchange of India |
ISIN | INE027H01010 |
Business Address | Capital Cyberscape, Gurugram, |
Sector | Health Care Providers & Services |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.maxhealthcare.in |
Phone | 91 22 2610 0461 |
You should never invest in Max Healthcare without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Max Stock, because this is throwing your money away. Analyzing the key information contained in Max Healthcare's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Max Healthcare Key Financial Ratios
There are many critical financial ratios that Max Healthcare's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Max Healthcare Institute reports annually and quarterly.Revenue | 54.06 B | ||||
Gross Profit | 40.78 B | ||||
EBITDA | 16.7 B | ||||
Net Income | 10.58 B | ||||
Total Asset | 120 B |
Max Healthcare Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 85.4B | 91.9B | 101.0B | 120.0B | 138.0B | 144.9B | |
Other Current Liab | 2.5B | 1.8B | 3.8B | 4.1B | 4.7B | 4.9B | |
Net Debt | 7.0B | 8.2B | 6.5B | 5.3B | 6.1B | 8.4B | |
Retained Earnings | (4.6B) | 1.5B | 12.3B | 21.9B | 25.2B | 26.4B | |
Accounts Payable | 4.4B | 4.4B | 5.4B | 6.8B | 7.8B | 8.2B | |
Cash | 6.3B | 3.1B | 427.5M | 9.8B | 11.3B | 11.8B | |
Other Assets | 8.6B | 10.2B | 8.7B | 1.0 | 1.15 | 1.09 | |
Net Receivables | 3.9B | 4.1B | 3.7B | 5.0B | 5.7B | 3.8B | |
Inventory | 538M | 613.6M | 762.3M | 798.4M | 918.2M | 964.1M | |
Other Current Assets | 560.8M | 480.2M | 1.3B | 1.5B | 1.7B | 1.8B | |
Total Liab | 29.1B | 29.1B | 26.9B | 35.9B | 41.3B | 24.9B | |
Total Current Assets | 11.2B | 10.0B | 19.4B | 17.1B | 19.6B | 20.6B | |
Short Term Debt | 886M | 1.1B | 845M | 1.2B | 1.3B | 1.9B | |
Intangible Assets | 23.3B | 26.6B | 26.1B | 26.3B | 30.2B | 15.2B | |
Common Stock | 9.7B | 9.7B | 9.7B | 9.7B | 11.2B | 7.5B | |
Other Liab | 2.9B | 11.2B | 13.5B | 10.4B | 12.0B | 9.4B | |
Net Tangible Assets | 19.9B | 8.5B | 11.7B | 23.4B | 27.0B | 28.3B | |
Long Term Debt | 8.4B | 6.3B | 5.0B | 10.6B | 9.5B | 6.3B | |
Net Invested Capital | 65.4B | 70.1B | 79.7B | 95.6B | 109.9B | 58.7B | |
Short Long Term Debt | 542.5M | 972.4M | 682.4M | 887.9M | 799.1M | 1.2B | |
Net Working Capital | 3.5B | 2.4B | 9.0B | 4.6B | 5.3B | 5.5B | |
Capital Stock | 9.7B | 9.7B | 9.7B | 9.7B | 11.2B | 9.1B |
Max Healthcare Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Interest Expense | 1.7B | 900.1M | 838.6M | 598.9M | 688.7M | 954.1M | |
Total Revenue | 24.8B | 38.8B | 45.6B | 54.1B | 62.2B | 65.3B | |
Gross Profit | 18.9B | 29.6B | 36.4B | 33.5B | 38.6B | 40.5B | |
Operating Income | 2.4B | 7.6B | 10.2B | 22.4B | 25.7B | 27.0B | |
Ebit | 1.1B | 8.4B | 11.5B | 14.3B | 16.4B | 17.2B | |
Ebitda | 2.8B | 10.6B | 13.8B | 16.7B | 19.2B | 20.2B | |
Cost Of Revenue | 5.9B | 9.2B | 9.2B | 20.5B | 23.6B | 24.8B | |
Income Before Tax | (686.5M) | 7.4B | 10.6B | 13.7B | 15.7B | 16.5B | |
Net Income | (1.4B) | 6.1B | 11.0B | 10.6B | 12.2B | 12.8B | |
Income Tax Expense | 458.5M | 1.3B | (397.9M) | 3.1B | 3.5B | 3.7B | |
Tax Provision | 458.5M | 1.3B | (397.9M) | 3.1B | 3.5B | 3.7B | |
Net Interest Income | (1.8B) | (1.0B) | 285.2M | 963.1M | 1.1B | 1.2B | |
Interest Income | 767.3M | 750.9M | 1.1B | 1.6B | 1.8B | 1.9B |
Max Healthcare Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Change To Inventory | 172.5M | (75.6M) | (148.7M) | 59M | 53.1M | 55.8M | |
Change In Cash | 5.2B | (3.2B) | (2.7B) | (3.9B) | (3.6B) | (3.4B) | |
Free Cash Flow | (5.6M) | 1.9B | 8.7B | 3.4B | 3.9B | 4.1B | |
Depreciation | 1.7B | 2.2B | 2.3B | 2.4B | 2.8B | 1.5B | |
Other Non Cash Items | 3.1B | 334.1M | (228.2M) | (713.5M) | (642.2M) | (610.0M) | |
Capital Expenditures | 1.2B | 5.6B | 3.4B | 7.9B | 9.0B | 9.5B | |
Net Income | (686.5M) | 7.4B | 10.6B | 10.6B | 12.2B | 12.8B | |
End Period Cash Flow | 6.3B | 3.1B | 427.5M | 9.8B | 11.3B | 11.8B | |
Investments | (730M) | (1.7B) | (11.9B) | (12.9B) | (11.6B) | (11.0B) | |
Net Borrowings | 5.8B | (8.2B) | (2.1B) | (2.2B) | (2.0B) | (1.9B) | |
Change To Netincome | 113M | 4.6B | 542.8M | (2.1B) | (1.9B) | (1.8B) |
Max Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Max Healthcare's current stock value. Our valuation model uses many indicators to compare Max Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Max Healthcare competition to find correlations between indicators driving Max Healthcare's intrinsic value. More Info.Max Healthcare Institute is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.55 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Max Healthcare Institute is roughly 1.80 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Max Healthcare's earnings, one of the primary drivers of an investment's value.Max Healthcare Institute Systematic Risk
Max Healthcare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Max Healthcare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was sixty with a total number of output elements of one. The Beta measures systematic risk based on how returns on Max Healthcare Institute correlated with the market. If Beta is less than 0 Max Healthcare generally moves in the opposite direction as compared to the market. If Max Healthcare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Max Healthcare Institute is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Max Healthcare is generally in the same direction as the market. If Beta > 1 Max Healthcare moves generally in the same direction as, but more than the movement of the benchmark.
Max Healthcare Institute Total Assets Over Time
Max Healthcare Thematic Clasifications
Max Healthcare Institute is part of Health Management investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Healthcare providers, hospitals. Major hospitals and healthcare providers
This theme covers Healthcare providers, hospitals. Major hospitals and healthcare providers. Get More Thematic Ideas
Health Management | View |
Max Healthcare March 4, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Max Healthcare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Max Healthcare Institute. We use our internally-developed statistical techniques to arrive at the intrinsic value of Max Healthcare Institute based on widely used predictive technical indicators. In general, we focus on analyzing Max Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Max Healthcare's daily price indicators and compare them against related drivers.
Information Ratio | 0.0134 | |||
Maximum Drawdown | 14.13 | |||
Value At Risk | (4.84) | |||
Potential Upside | 3.73 |
Other Information on Investing in Max Stock
Max Healthcare financial ratios help investors to determine whether Max Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Max with respect to the benefits of owning Max Healthcare security.